ArticleBlood cancer journal2021

Identification of novel anti-tumor therapeutic target via proteomic characterization of ubiquitin receptor ADRM1/Rpn13.

Yan Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.